Vanguard Group’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-795,549
| Closed | -$3.22M | – | 4526 |
|
|
2023
Q4 | $3.22M | Buy |
795,549
+6,429
| +0.8% | +$26K | ﹤0.01% | 3439 |
|
|
2023
Q3 | $2.12M | Buy |
789,120
+57,695
| +8% | +$155K | ﹤0.01% | 3558 |
|
|
2023
Q2 | $6.82M | Buy |
731,425
+30,464
| +4% | +$284K | ﹤0.01% | 3159 |
|
|
2023
Q1 | $6.22M | Buy |
700,961
+62,489
| +10% | +$555K | ﹤0.01% | 3203 |
|
|
2022
Q4 | $3.18M | Buy |
638,472
+12,529
| +2% | +$62.4K | ﹤0.01% | 3493 |
|
|
2022
Q3 | $3.63M | Sell |
625,943
-3,371
| -0.5% | -$19.6K | ﹤0.01% | 3490 |
|
|
2022
Q2 | $3.48M | Buy |
629,314
+142,952
| +29% | +$791K | ﹤0.01% | 3552 |
|
|
2022
Q1 | $5.61M | Sell |
486,362
-396
| -0.1% | -$4.57K | ﹤0.01% | 3474 |
|
|
2021
Q4 | $6.17M | Buy |
+486,758
| New | +$6.17M | ﹤0.01% | 3494 |
|